Skip to main content

scPharmaceuticals Inc.

SCPHDelisted Oct 7, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001604950

scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.

Q2 2024 vs. Q1 2024

How the institutions holding scPharmaceuticals Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of SCPH: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders7677+1
Shares26.7M27.8M+1.08M (+4.0%)
Value$134.2M$121.0M−$13.2M (−9.8%)

New holders (12)

Institutions that held scPharmaceuticals Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to SCPH in Q2 2024
InstitutionSharesValue% of portfolio
Bank of Montreal351,806$1.54M0.00%
PDT Partners, LLC17,351$75.5K0.01%
Corebridge Financial, Inc.15,274$66.4K0.00%
Mirae Asset Global ETFs Holdings Ltd.14,643$63.7K0.00%
Trexquant Investment LP13,995$60.9K0.00%
Voya Investment Management LLC11,501$50.0K0.00%
Pinnacle Wealth Planning Services, Inc.11,232$48.9K0.01%
Massmutual Trust Co FSB389$1.69K0.00%
CWM, LLC268$1.00K0.00%
Nisa Investment Advisors, LLC144$6260.00%
International Assets Investment Management, LLC100$4350.00%
Russell Investments Group, Ltd.44$1910.00%

Sold out (11)

Institutions that held scPharmaceuticals Inc. at the end of Q1 2024 and filed for Q2 2024 without it.